Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move
Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Read More 2 minute read Technology Industry News bswift launches integrated personalization platform to redefine benefits engagement bswift LLC, a leading provider of employee benefits technology and administration, has introduced a groundbreaking personalization and engagement… byPallavi MadhirajuNovember 18, 2024